Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better
Rui Mao, Wanqing Kong, Yukai He
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
Marisa K. Kilgour, Donald Bastin, Seung‐Hwan Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition
Irene Andreu-Saumell, Alba Rodríguez-García, Vanessa Mühlgrabner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Encoding and display technologies for combinatorial libraries in drug discovery: The coming of age from biology to therapy
Yu Fan, Ruibing Feng, Xinya Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3362-3384
Open Access | Times Cited: 6
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
Piotr Celichowski, Marcello Turi, Sandra Charvátová, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
Renato Kaylan Alves de Oliveira França, Igor Cabral Studart, Marcus Rafael Lobo Bezerra, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1903-1903
Open Access | Times Cited: 14
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Greta Maria Paola Giordano Attianese, Sarah Ash, Melita Irving
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 166-198
Open Access | Times Cited: 14
Outsmarting trogocytosis to boost CAR NK/T cell therapy
Faezeh Ramezani, Ahmad Reza Panahi Meymandi, Behnia Akbari, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study
Yunlin Zhang, Ruchi P. Patel, Ki Hyun Kim, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges
Dennis Christoph Harrer, Sin‐Syue Li, Marcell Kaljanac, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Precision Targeting and Genetically Modified T Cells for Targeting Cancer Cells
Dr Ammar A. Razzak Mahmood, Sudhakar Srinivasan, Challaraj Emmanuel E. S
International Journal of Trends in OncoScience (2024), pp. 1-9
Open Access | Times Cited: 2
Optical sensing and control of T cell signaling pathways
Hae Nim Lee, Seung Eun Lee, Kyung-Soo Inn, et al.
Frontiers in Physiology (2024) Vol. 14
Open Access | Times Cited: 2
A method for rapid nanobody screening with no bias of the library diversity
Zhiqing Tao, Zhao Xiao-ling, Huan Wang, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108966-108966
Open Access | Times Cited: 2
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells
Sophia Schreiber, Lisa S. Dressler, Eva Loffredo‐Verde, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Chimeric antigen receptor T cells for acute myeloid leukemia
Viktor Fetsch, Robert Zeiser
European Journal Of Haematology (2023) Vol. 112, Iss. 1, pp. 28-35
Open Access | Times Cited: 7
Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance
M. Frank Erasmus, Molly Dovner, Fortunato Ferrara, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 6
In Synergy: Optimizing CAR T Development and Personalizing Patient Care Using Single-Cell Technologies
Oren Barboy, Yonatan Katzenelenbogen, Rotem Shalita, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1546-1555
Closed Access | Times Cited: 5
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma
Sophia Stock, Luisa Fertig, Adrian Gottschlich, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 1
B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors
Siok Ping Yeo, Lindsay Kua, Jin Wei Tan, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 6, pp. 1410-1429
Open Access | Times Cited: 1
State of the art and perspectives of CAR-T cell therapy for neuroblastoma
Dzmitry Lutskovich, Alexander Meleshko, Mikalai Katsin
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1122-1131
Closed Access | Times Cited: 1
Engineering strategies to mitigate toxicities associated with CAR‐T cell therapy
Tyler Wolter, Yixin Wang, Quanyin Hu
BMEMat (2024)
Open Access | Times Cited: 1
The peptide-based bispecific CAR T cells target EGFR and tumor stroma for effective cancer therapy
Cuijuan Liu, Qianqian Wang, Lin Li, et al.
International Journal of Pharmaceutics (2024) Vol. 663, pp. 124558-124558
Closed Access | Times Cited: 1
A method for rapid nanobody screening with no bias of the library diversity
Zhiqing Tao, Zhao Xiao-ling, Huan Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Recombinant Human CD19 in CHO-K1 Cells: Glycosylation Patterns as a Quality Attribute of High Yield Processes
Magdalena Billerhart, Monika Hunjadi, Vanessa Hawlin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10891-10891
Open Access | Times Cited: 2
Overcoming toxicity challenges in CAR-T therapy: mechanisms and mitigation strategies
Zixuan Zhuang
(2024), pp. 41-41
Closed Access
Page 1 - Next Page

Scroll to top